Flourish has secured $500 million in its Series B funding round, reaching a $2.5 billion valuation. This significant capital infusion will be used to advance their mission of reinventing AI by studying real neurons. The company's specific focus on biological inspiration for AI development marks a distinct approach in the competitive landscape.